Literature DB >> 6799480

In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their beta-lactamases.

D M Livermore, J D Williams.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6799480     DOI： 10.1093/jac/8.suppl_e.29

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  16 in total

Review 1.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

2.  Aztreonam in the treatment of severe urinary tract infections in pediatric patients.

Authors:  F Rusconi; B M Assael; A Boccazzi; R Colombo; R M Crossignani; L Garlaschi; L Rancilio
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

3.  Enzymatic inactivation of aztreonam by faecal enzyme preparations from healthy volunteers.

Authors:  G W Welling; G Groen; S Welling-Wester; H G de Vries-Hospers; D van der Waaij
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

4.  In vitro activity of azthreonam and Ro 17-2301 against multiresistant Pseudomonas aeruginosa strains.

Authors:  P Campos; A Vera; F Martin-Luengo
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

5.  Self-protection of Pseudomonas syringae pv. "tabaci" from its toxin, tabtoxinine-beta-lactam.

Authors:  T J Knight; R D Durbin; P J Langston-Unkefer
Journal:  J Bacteriol       Date:  1987-05       Impact factor: 3.490

Review 6.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Comparative activities of aztreonam and cefotaxime against Escherichia coli and Bacteroides spp. in pure and mixed cultures.

Authors:  F Soriano; M C Ponte
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

8.  In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli.

Authors:  M A Buesing; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

9.  Evaluation of aztreonam in the treatment of severe bacterial infections.

Authors:  J Romero-Vivas; M Rodríguez-Créixems; E Bouza; T Hellín; A Guerrero; J Martínez-Beltrán; M García de la Torre
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

Review 10.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.